Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis
Primary Purpose
Ankle Osteoarthritis
Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Botulinum Toxin A (Allergan, Inc, Irvine CA)
Hyalgan (Hyalgan, Fidia , Italy)
Sponsored by

About this trial
This is an interventional treatment trial for Ankle Osteoarthritis focused on measuring osteoarthritis, botulinum toxin, hyaluronate
Eligibility Criteria
Inclusion Criteria:
- an age of 20-85 years with diagnosis of ankle osteoarthritis
- unilateral ankle pain that had lasted for at least 6 months, with no significant benefit from conservative treatment or with an inability to tolerate the side effects of medications
- ankle radiographs taken within 6 months equivalent to grade 2 on the Kellgren-Lawrence grading system
- a current total Ankle Osteoarthritis Scale (AOS) score of >3 and < 9 (possible range, 0-10)
- a normal activity level-i.e., not bedridden or confined to a wheelchair, and are able to walk 30 meters without the aid of a walker, crutches or cane
- no changes in shoes or orthotic devices during the study period.
Exclusion Criteria:
- pregnancy or lactation in women
- lower leg trauma other than ankle trauma
- previous surgery involving the spine, hip or knee
- the presence of an active joint infections of foot or ankle
- previous surgery or arthroscopy on the ankle within 12 months
- history of chicken or egg allergy
- intraarticular steroid or hyaluronate injection in the treated ankle within the previous 6 months
- treatment with anticoagulants or immunosuppressives
- a history of rheumatoid arthritis, gout, or any other inflammatory arthropathy
- the presence of other comorbidity (such as neoplasms, diabetes mellitus, paresis or recent trauma) or poor health status that would interfere with the clinical assessments during the study.
Sites / Locations
- Kaohsiung Veterans General Hospital, No 386, Ta-Chung 1st Road
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
The Botulinum Toxin A group
The hyaluronate group (Hyalgan, Italy)
Arm Description
The Botulinum Toxin A group received intraarticular injections of 100 units of Botulinum Toxin A (Allergan, Inc, Irvine CA) reconstituted in 2 cc normal saline.
The hyaluronate group received intraarticular injections of 2 ml sodium hyaluronate (Hyalgan, molecular weight 500-730kDa, Fidia Pharmaceutical Corporation, Abano Terme, Italy) and subsequent 6 sessions of rehabilitation exercise for 50 miniutes/day, 3 days per week for 2 weeks and home exercise for 2 weeks .
Outcomes
Primary Outcome Measures
Ankle Osteoarthritis Scale (AOS) score
The AOS is a patient-rated, validated outcome measure that includes nine items on a pain subscale and nine items on a disability subscale.Using the AOS, a score of 0 represent no pain or disability and 10 represent worst pain or disability imaginable
Secondary Outcome Measures
AOFAS ankle/hindfoot score
AOFAS ankle/hindfoot score is a 100-point scale that devotes 40 points to pain, 50 points to function and 10 points to alignment.
Visual analog scale (VAS)
The patient rate the intensity of average ankle movement pain in the previous week using a 10-cm horizontal Visual analog scale (VAS)
Single-leg stance test (SLS)
Single-leg stance test (SLS) is done by raising one foot up without touching it to the supported lower extremity with ankle OA and maintain balance for as long as possible
Timed " Up-and-Go" test (TUG)
A Timed " Up-and-Go" test (TUG) measures functional mobility and the dynamic balance of an individual.
global Patients satisfaction
This rating is based on a 7-point categorical scale ranging from completely satisfied, satisfied, somewhat satisfied, no change, somewhat unsatisfied, unsatisfied to completely unsatisfied.
adverse effects
patients recorded any systemic and local adverse effects (defined as any unwanted effect whether it was thought to be related to the study or not) on a diary card.
Full Information
NCT ID
NCT01760577
First Posted
December 30, 2012
Last Updated
January 3, 2013
Sponsor
Kaohsiung Veterans General Hospital.
1. Study Identification
Unique Protocol Identification Number
NCT01760577
Brief Title
Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis
Official Title
Comparing Effects of Intraarticular Botulinum Toxin A Versus Hyaluronate Plus Rehabilitation Exercise in Patients With Unilateral Ankle Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
May 2010 (undefined)
Primary Completion Date
May 2012 (Actual)
Study Completion Date
November 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kaohsiung Veterans General Hospital.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare the effects of intraarticular Botulinum Toxin A versus intraarticular hyaluronate plus rehabilitation exercise in patients with ankle osteoarthritis.
Detailed Description
Recent pilot studies report that intraarticular injection of Botulinum Toxin A into painful joints of patients with various types of arthritis leads to significant and durable improvement in pain and function and is safe to use. To date, there is no published literature that evaluate the effects of intraarticular Botulinum Toxin A in the treatment of ankle OA. Sun el al reported that 3 or 5 weekly injection of hyaluronate may improve pain and physical function in patients with ankle OA and the treatment effects may last for 6 months. The effect of one injection of hyaluronate plus exercise had never been studied. The purpose of this study is to compare the effects of intraarticular Botulinum Toxin A versus intraarticular hyaluronate plus rehabilitation exercise for patients with ankle OA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ankle Osteoarthritis
Keywords
osteoarthritis, botulinum toxin, hyaluronate
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)
8. Arms, Groups, and Interventions
Arm Title
The Botulinum Toxin A group
Arm Type
Experimental
Arm Description
The Botulinum Toxin A group received intraarticular injections of 100 units of Botulinum Toxin A (Allergan, Inc, Irvine CA) reconstituted in 2 cc normal saline.
Arm Title
The hyaluronate group (Hyalgan, Italy)
Arm Type
Active Comparator
Arm Description
The hyaluronate group received intraarticular injections of 2 ml sodium hyaluronate (Hyalgan, molecular weight 500-730kDa, Fidia Pharmaceutical Corporation, Abano Terme, Italy) and subsequent 6 sessions of rehabilitation exercise for 50 miniutes/day, 3 days per week for 2 weeks and home exercise for 2 weeks .
Intervention Type
Drug
Intervention Name(s)
Botulinum Toxin A (Allergan, Inc, Irvine CA)
Other Intervention Name(s)
100 units of Botulinum Toxin A in 2 cc NS
Intervention Description
patients received intraarticular injections by the same experienced physician using aseptic procedures.
Intervention Type
Drug
Intervention Name(s)
Hyalgan (Hyalgan, Fidia , Italy)
Other Intervention Name(s)
2 ml Hyalgan, molecular weight 500-730kDa, Fidia , Italy
Intervention Description
The rehabilitation program consists of 6 sessions of rehabilitation exercise for 50 miniutes/day, 3 days per week for 2 weeks and home exercise program for another 2 weeks.
Primary Outcome Measure Information:
Title
Ankle Osteoarthritis Scale (AOS) score
Description
The AOS is a patient-rated, validated outcome measure that includes nine items on a pain subscale and nine items on a disability subscale.Using the AOS, a score of 0 represent no pain or disability and 10 represent worst pain or disability imaginable
Time Frame
at 6 months after the injection
Secondary Outcome Measure Information:
Title
AOFAS ankle/hindfoot score
Description
AOFAS ankle/hindfoot score is a 100-point scale that devotes 40 points to pain, 50 points to function and 10 points to alignment.
Time Frame
pre-injection and at 2 weeks, 1 month, 3 months, and 6 months post injection.
Title
Visual analog scale (VAS)
Description
The patient rate the intensity of average ankle movement pain in the previous week using a 10-cm horizontal Visual analog scale (VAS)
Time Frame
pre-injection and at 2 weeks, 1 month, 3 months, and 6 months post injection
Title
Single-leg stance test (SLS)
Description
Single-leg stance test (SLS) is done by raising one foot up without touching it to the supported lower extremity with ankle OA and maintain balance for as long as possible
Time Frame
pre-injection and at 2 weeks, 1 month, 3 months, and 6 months post injection
Title
Timed " Up-and-Go" test (TUG)
Description
A Timed " Up-and-Go" test (TUG) measures functional mobility and the dynamic balance of an individual.
Time Frame
pre-injection and at 2 weeks, 1 month, 3 months, and 6 months post injection
Title
global Patients satisfaction
Description
This rating is based on a 7-point categorical scale ranging from completely satisfied, satisfied, somewhat satisfied, no change, somewhat unsatisfied, unsatisfied to completely unsatisfied.
Time Frame
at 2 weeks, 1 month, 3 months, and 6 months post injection.
Title
adverse effects
Description
patients recorded any systemic and local adverse effects (defined as any unwanted effect whether it was thought to be related to the study or not) on a diary card.
Time Frame
at 2 weeks, 1 month, 3 months, and 6 months post injection.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
an age of 20-85 years with diagnosis of ankle osteoarthritis
unilateral ankle pain that had lasted for at least 6 months, with no significant benefit from conservative treatment or with an inability to tolerate the side effects of medications
ankle radiographs taken within 6 months equivalent to grade 2 on the Kellgren-Lawrence grading system
a current total Ankle Osteoarthritis Scale (AOS) score of >3 and < 9 (possible range, 0-10)
a normal activity level-i.e., not bedridden or confined to a wheelchair, and are able to walk 30 meters without the aid of a walker, crutches or cane
no changes in shoes or orthotic devices during the study period.
Exclusion Criteria:
pregnancy or lactation in women
lower leg trauma other than ankle trauma
previous surgery involving the spine, hip or knee
the presence of an active joint infections of foot or ankle
previous surgery or arthroscopy on the ankle within 12 months
history of chicken or egg allergy
intraarticular steroid or hyaluronate injection in the treated ankle within the previous 6 months
treatment with anticoagulants or immunosuppressives
a history of rheumatoid arthritis, gout, or any other inflammatory arthropathy
the presence of other comorbidity (such as neoplasms, diabetes mellitus, paresis or recent trauma) or poor health status that would interfere with the clinical assessments during the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shu-Fen Sun, MD
Organizational Affiliation
Kaohsiung Veterans General Hospital, Taiwan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaohsiung Veterans General Hospital, No 386, Ta-Chung 1st Road
City
Kaohsiung
ZIP/Postal Code
813
Country
Taiwan
12. IPD Sharing Statement
Citations:
PubMed Identifier
16635582
Citation
Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL, Hsu YW, Chou MC. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage. 2006 Sep;14(9):867-74. doi: 10.1016/j.joca.2006.03.003. Epub 2006 Apr 24.
Results Reference
background
PubMed Identifier
21938376
Citation
Sun SF, Hsu CW, Sun HP, Chou YJ, Li HJ, Wang JL. The effect of three weekly intra-articular injections of hyaluronate on pain, function, and balance in patients with unilateral ankle arthritis. J Bone Joint Surg Am. 2011 Sep 21;93(18):1720-6. doi: 10.2106/JBJS.J.00315.
Results Reference
background
PubMed Identifier
16785116
Citation
Mahowald ML, Singh JA, Dykstra D. Long term effects of intra-articular botulinum toxin A for refractory joint pain. Neurotox Res. 2006 Apr;9(2-3):179-88. doi: 10.1007/BF03033937.
Results Reference
background
PubMed Identifier
19131763
Citation
Singh JA, Mahowald ML, Kushnaryov A, Goelz E, Dykstra D. Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain. J Clin Rheumatol. 2009 Feb;15(1):35-8. doi: 10.1097/RHU.0b013e3181953b14. No abstract available.
Results Reference
background
PubMed Identifier
19375681
Citation
Singh JA, Mahowald ML, Noorbaloochi S. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Transl Res. 2009 May;153(5):205-16. doi: 10.1016/j.trsl.2009.02.004. Epub 2009 Mar 13.
Results Reference
background
PubMed Identifier
19351542
Citation
Mahowald ML, Krug HE, Singh JA, Dykstra D. Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain. Toxicon. 2009 Oct;54(5):658-67. doi: 10.1016/j.toxicon.2009.03.028. Epub 2009 Apr 5.
Results Reference
background
PubMed Identifier
12887389
Citation
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003 Jul-Aug;43 Suppl 1:S9-15. doi: 10.1046/j.1526-4610.43.7s.3.x.
Results Reference
background
PubMed Identifier
19468874
Citation
Sun SF, Chou YJ, Hsu CW, Chen WL. Hyaluronic acid as a treatment for ankle osteoarthritis. Curr Rev Musculoskelet Med. 2009 Jun;2(2):78-82. doi: 10.1007/s12178-009-9048-5. Epub 2009 Mar 13.
Results Reference
background
PubMed Identifier
8024624
Citation
Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, Sorsa T, Pertovaara A, Polak JM. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994 Jul;37(7):965-82. doi: 10.1002/art.1780370701. No abstract available.
Results Reference
background
PubMed Identifier
24502534
Citation
Sun SF, Hsu CW, Lin HS, Chou YJ, Chen JY, Wang JL. Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. J Foot Ankle Res. 2014 Feb 6;7(1):9. doi: 10.1186/1757-1146-7-9.
Results Reference
derived
Learn more about this trial
Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis
We'll reach out to this number within 24 hrs